GNMSF GENMAB A/S

NEUTRAL Impact: 2/10 6-K
Horizon immediate Filed Apr 1, 2026 Processed 2mo ago SEC 0001434265-26-000054
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GNMSF ▼ -3.68% at T+20d
NEUTRAL call ✗ call lost -3.68% · α vs SPY -13.40% · entry $265.00 → $255.25
Next anchor: T+60d in 19d
Last close $249.45 (close Jun 8) · -5.87% from $265.00 entry
Entry anchored
Apr 1, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.08%
$265.00
settled 2mo ago
T+5d
+12.60%
call +12.60% · α +8.83%
$298.38
settled 2mo ago
T+20d
-3.68%
call -3.68% · α -13.40%
$255.25
settled 6w ago
T+60d
call — · α —
in 19d

Price Chart

Loading chart...

Executive Summary

Genmab A/S announced that Orbis Investment Management Limited has acquired a 5.01% stake in the company, making it a major shareholder. This is a routine regulatory disclosure with no material financial impact.

Actionable Insight

This is a routine disclosure with no immediate trading implications. Monitor for potential future filings that might indicate activist intentions, but this standalone event does not suggest any strategic changes.

Key Facts

  • Orbis Investment Management Limited now holds 3,221,620 shares in Genmab AS
  • This represents 5.01% of the share capital and voting rights
  • The stake crossed the 5% threshold on March 31, 2026
  • This is a standard regulatory filing under Danish capital markets rules

Financial Impact

No financial impact - this is a passive stake disclosure

ownershipvoting_rights

Risk Factors

  • Potential for future activist involvement if Orbis increases its stake
  • Market perception of institutional interest could influence sentiment

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000054
Document: gmab_20260401xx6k.htm0001434265-26-000054
Document: gmab_20260401xxex99d2.htm0001434265-26-000054
Document: 0001434265-26-000054-index-headers.html0001434265-26-000054
Document: 0001434265-26-000054-index.html0001434265-26-000054
Document: 0001434265-26-000054.txt0001434265-26-000054
10 reports for GNMSF
Performance horizon
Filters
Rows
Reports for GNMSF — sortable, filterable
Type Now
May 29, 2026
11d ago
6-K
NEUTRAL ★ 2/10
$251.55 $249.45▼ −0.83%▲ +1.92%$249.45 (−0.83%)
May 13, 2026
27d ago
6-K
NEUTRAL ★ 2/10
$268.24 $265.27▼ −1.11%▲ +0.05%$249.45 (−7.00%)
May 12, 2026
28d ago
6-K
NEUTRAL ★ 1/10
$264.64 $265.27▲ +0.24%▲ +0.16%$249.45 (−5.74%)
May 8, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$259.60 $265.27▲ +2.18%▲ +2.27%$249.45 (−3.91%)
Apr 17, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$281.75 $271.83▼ −3.52%▼ −4.08%$249.45 (−11.46%)
Apr 17, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$281.75 $271.83▼ −3.52%▼ −4.08%$249.45 (−11.46%)
Apr 14, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$273.25 $281.75▲ +3.11%▲ +1.72%$249.45 (−8.71%)
Apr 1, 2026
9w ago
6-K
NEUTRAL ★ 2/10
$265.00 $298.38▲ +12.60%▲ +8.83%$249.45 (−5.87%)
Apr 1, 2026
9w ago
6-K
NEUTRAL ★ 2/10
$265.00 $298.38▲ +12.60%▲ +8.83%$249.45 (−5.87%)
Mar 30, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$265.00 $281.06▲ +6.06%▲ +2.12%$249.45 (−5.87%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 7h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access